journal article·2025-06

Triphenylamine‐Substituted Nile Red Derivatives with Efficient Reactive Oxygen Species Generation for Robust and Broad‐Spectrum Antimicrobial Photodynamic Therapy and Abscess Wound Healing

Jianan Dai, Laiping Fang, Zhijin Fan, Xuan Wang, Jie Hua, He Dong, Yike Tu, Shufang Li, Kuo He, Jin Fang, Lifeng Hang, Shumei Li, Jin Wang, Wei Wang, Ping'an Ma, Guihua Jiang

Advanced Functional Materials· Volume 35· Issue 23
Publisher page

Abstract

Abstract Infections caused by drug‐resistant bacteria represent a major contributor to high mortality rates, underscoring the urgent need for effective non‐antibiotic drugs and alternative therapies. Antimicrobial photodynamic therapy (aPDT) emerges as an innovative treatment due to its minimal drug resistance. Herein, a series of Nile Red derivatives is synthesized by a donor engineering strategy. Notably, NTPA featuring triphenylamine (TPA) as the electron‐donating group, exhibited the highest production of reactive oxygen species (ROS). The enhanced electron donating‐accepting (D‐A) property effectively reduced the energy gap between S1 and T1 (ΔES‐T), facilitating intersystem crossing (ISC) with a larger spin‐orbit coupling (SOC) constant. Furthermore, the twisted conformation profoundly suppressed the quenching of ROS. As expected, an over 470‐fold increase in ROS production is observed, predominantly comprising type‐I ROS. NTPA nanoparticles (NPs) exhibited exceptional in vitro killing ability against various drug‐resistant bacteria, with inhibition efficiency even reaching 99.9%. In the methicillin‐resistant staphylococcus aureus (MRSA)‐induced abscess model, NTPA NPs facilitated complete wound healing within just 8 days following a single administration and irradiation, highlighting their exceptional bactericidal and wound‐healing promotion capabilities. Overall, this work inspired the construction of efficient Nile Red‐based type‐I photosensitizers (PSs) and the development of a new broad‐spectrum aPDT method for drug‐resistant bacteria treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Information Technology, Jilin Engineering Research Center of Optoelectronic Materials and Devices Jilin Normal University Siping 136000 P. R. China

Jilin Provincial Key Laboratory of Wide Bandgap Semiconductor Material Growth and Device Applications Jilin Normal University Changchun 130103 P. R. China

Guangdong Second Provincial General Hospital School of Medicine Jinan University Guangzho 518037 P. R. China

Institute for Engineering Medicine Kunming Medical University Kunming 650500 P. R. China

The Department of Medical Imaging The Affiliated Guangdong Second Provincial General Hospital of Jinan University Guangzhou 518037 P. R. China

State Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130012 P. R. China

School of Pharmaceutical Sciences Southern Medical University Guangzhou 510515 P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jilin Province · China Postdoctoral Science Foundation

References (36)

Show source-provided references
1. 10.1016/S0140-6736(21)02724-010.1016/S0140-6736(21)02724-0 ↗
2. 10.1016/S1473-3099(15)00424-710.1016/S1473-3099(15)00424-7 ↗
3. 10.1002/advs.20190084010.1002/advs.201900840 ↗
4. 10.1002/adhm.20240210310.1002/adhm.202402103 ↗
5. 10.1016/S0140-6736(24)01867-110.1016/S0140-6736(24)01867-1 ↗
6. 10.1038/s41579-020-0340-010.1038/s41579-020-0340-0 ↗
7. 10.1038/s41579-019-0288-010.1038/s41579-019-0288-0 ↗
8. 10.1016/j.ajps.2024.10092610.1016/j.ajps.2024.100926 ↗
9. 10.1002/adfm.20240147710.1002/adfm.202401477 ↗
10. 10.1021/acsnano.2c0120610.1021/acsnano.2c01206 ↗
11. 10.1002/anie.20221238610.1002/anie.202212386 ↗
12. 10.1021/acsnano.2c0073410.1021/acsnano.2c00734 ↗
13. 10.1016/j.actbio.2024.02.00510.1016/j.actbio.2024.02.005 ↗
14. 10.1002/advs.20210407910.1002/advs.202104079 ↗
15. 10.1021/jacs.0c1097210.1021/jacs.0c10972 ↗
16. 10.1021/jacs.2c1194010.1021/jacs.2c11940 ↗
17. 10.1016/1011-1344(89)80022-310.1016/1011-1344(89)80022-3 ↗
18. 10.1002/agt2.25610.1002/agt2.256 ↗
19. 10.1039/C5SC01733E10.1039/C5SC01733E ↗
20. 10.1021/acs.accounts.0c0060610.1021/acs.accounts.0c00606 ↗
21. 10.1002/anie.20181032610.1002/anie.201810326 ↗
22. 10.1021/jp075248q10.1021/jp075248q ↗
23. 10.1002/anie.20180083410.1002/anie.201800834 ↗
24. 10.1002/adma.20210814610.1002/adma.202108146 ↗
25. 10.1021/jacs.7b0087310.1021/jacs.7b00873 ↗
26. 10.1038/s41467-018-05476-y10.1038/s41467-018-05476-y ↗
27. 10.1039/D2SC01260J10.1039/D2SC01260J ↗
28. 10.1002/adma.20240602610.1002/adma.202406026 ↗
29. 10.1002/agt2.710.1002/agt2.7 ↗
30. 10.1039/C6NR03656B10.1039/C6NR03656B ↗
31. 10.1021/acs.jpcb.0c0065410.1021/acs.jpcb.0c00654 ↗
32. 10.1021/acsnano.3c0654210.1021/acsnano.3c06542 ↗
33. 10.1063/1.271027410.1063/1.2710274 ↗
34. 10.1021/ja067946e10.1021/ja067946e ↗
35. 10.1039/D3TC01481A10.1039/D3TC01481A ↗
36. 10.1021/ja304799a10.1021/ja304799a ↗